{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Wills Eye Hospital CME
Wills Eye Hospital Continuing Medical Education
  • Sign In
  • LIVE COURSES
  • ON DEMAND COURSES
  • REGULARLY SCHEDULED SERIES
  • NEO (HR)
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
[email protected]
Sign in with your Email and Password
Enter your email and password to login:

*
*
Login

New to Wills Eye Hospital CME? Create an Account:

Create New Account
Forgot Your Password?
NOTE: Your old login from the previous Knowledge Portal will no longer work in this new system. Your log-in is the email address in your new Knowledge Portal account and the password you set for this account.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • BA
  • BHSA
  • BS
  • CNA
  • CO
  • COMT
  • CPO
  • CPOA
  • CPOT
  • CRA
  • DO
  • DVM
  • LPN
  • MBBS
  • MBChB
  • MD
  • MD, FACS
  • MD, MBA
  • MD, MPH
  • MD, MS, MBA, MPH
  • MD, PhD
  • MPH
  • MS
  • MSE
  • MSN
  • MSN, PPCNP-BC
  • OD
  • Other
  • PhD
  • Physician Assistant
  • PPCNP-BC
  • RN
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

79th Annual Wills Eye Conference

  • Overview
  • Register
  • Disclosures
  • Schedule
  • Abstracts
Add to Calendar 79th Annual Wills Eye Conference 4/15/2027 7:30:00 AM 4/16/2027 5:10:00 PM America/New_York For More Details: https://willseye.cloud-cme.com/willsconf27 Description: This is a two-day conference designed for comprehensive ophthalmologists, specialists, and allied health personnel. The conference will review clinical, diagnostic, and therapeutic approaches to eye problems related to all ophthalmic subspecialties. In a didactic format, nationally recognized physicians will present the current trends in diseases and treatment options for cornea, retina, oculoplastic surgery, and other... Marriott Old City (Philadelphia) false MM/DD/YYYY


Date & Location
Thursday, April 15, 2027, 7:30 AM - Friday, April 16, 2027, 5:10 PM, Marriott Old City (Philadelphia), Philadelphia, PA

Target Audience
Specialties - ALL

Credits
AMA PRA Category 1 Credits™ (13.50 hours), Non-Physician Attendance (13.50 hours)

Overview

This is a two-day conference designed for comprehensive ophthalmologists, specialists, and allied health personnel. The conference will review clinical, diagnostic, and therapeutic approaches to eye problems related to all ophthalmic subspecialties. In a didactic format, nationally recognized physicians will present the current trends in diseases and treatment options for cornea, retina, oculoplastic surgery, and other ophthalmic topics.


Objectives
At the conclusion of this activity, learners will be able to:

  1. Evaluate current evidence regarding established and emerging diagnostic, medical, and surgical approaches to ophthalmic disease and determine their appropriate role in patient care.
  2. Compare traditional and emerging treatment options across ophthalmic subspecialties and select appropriate management strategies based on disease characteristics and patient-specific factors.
  3. Apply current evidence, clinical guidelines, and standards of care to the diagnosis and management of common and complex ophthalmic conditions.
  4. Incorporate appropriate advances in diagnostic technologies, medical therapies, and surgical techniques into clinical practice to improve the evaluation and management of patients with ophthalmic disease.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Wills Eye Hospital and the Wills Eye Alumni Society. Wills Eye Hospital is accredited by the ACCME to provide continuing medical education for physicians.

 

AMA PRA Statement
Wills Eye Hospital designates this Live Activity for a maximum of 13.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Keywords: LIVEACCMECataract & Primary Eye CareComprehensiveCornea and External DiseaseGlaucomaNeuro-OphthalmologyOcular OncologyOcular PathologyOculoplastic and Orbital SurgeryPediatrics and StrabismusRetina and VitreousCME

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Michael D Abramoff, MD, PhD
University of Iowa
Faculty
Private Corp Stock-Digital Diagnostics, Inc|Executive-Digital Diagnostics, Inc|Royalties or Patent Beneficiary-Digital Diagnostics, Inc
Clara Chan, MD
University of Toronto
Canada
Faculty
Consulting Fee-AbbVie|Consulting Fee-Admare Bioinnovations|Consulting Fee-Apotex|Consulting Fee-Aurion|Grant or research support-Aurion|Consulting Fee-Bausch + Lomb|Grant or research support-Corneat|Grant or research support-Claris Bio|Consulting Fee-Vital Tears|Consulting Fee-Johnson & Johnson|Consulting Fee-Kala Pharmaceuticals|Consulting Fee-Labtician|Consulting Fee-Sun Pharmaceutical Industries|Consulting Fee-Thea Pharmacueticals|Consulting Fee-Pharma|Grant or research support-Design Therapeutics|Consulting Fee-Theianova
Linda Dagi, MD
CHOF
Faculty
Consulting Fee-Diopter Labs
Faculty Photos
Ralph C. Eagle Jr., MD
Director
Wills Eye Hospital
Faculty
Public Corp Stock-Merck
Tommy Edison, BA
N/A
Faculty
Nothing to disclose
David Fell, MD
Faculty
Faculty Photos
Nicole Fram, MD
Advanced Vision Care
Faculty
Honoraria-Alcon|Consulting Fee-Alcon|Consulting Fee-Alderya (Relationship has ended)|Advisor-Aurion (Relationship has ended)|Consulting Fee-Aurion (Relationship has ended)|Consulting Fee-CorneaGen (Relationship has ended)|Advisor-CorneaGen (Relationship has ended)|Consulting Fee-Glaukos Corporation|Consulting Fee-Johnson & Johnson|Advisor-Johnson & Johnson|Honoraria-Johnson & Johnson|Consulting Fee-New World Medical (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Ocular Science|Other: Clinical Trial Investigator-Ocular Therapeutix (Relationship has ended)|Advisor-Orasis Pharmaceuticals|Consulting Fee-RxSight (Relationship has ended)|Consulting Fee-Zeiss|Other: Clinical Trial Investigator-Zeiss (Relationship has ended)|Consulting Fee-AbbVie|Consulting Fee-Bausch + Lomb|Consulting Fee-Beaver-Visitec International|Honoraria-Dompé |Consulting Fee-Emmecell|Honoraria-MicroSurgical Technology|Consulting Fee-Mani Medical |Consulting Fee-Simpliphi Technologies|Consulting Fee-Tarsus
Jeffrey Goldberg, MD, PhD
Byers Eye Institute at Stanford
Faculty
Consulting Fee-Merck, Astellas, Annexon, Thea, Neurotech, Roche, Emmecell, Peripherex, Bayer, Kowa,
Faculty Photos
Colleen Halfpenny, MD
Wills
Faculty
Nothing to disclose
Faculty Photos
Sadeer B. Hannush, MD
Sadeer B Hannush MD
Faculty
Faculty Photos
Shruthi Harish, MD
Wills Eye Hospital
Faculty
Advisor-Catalyst pharmaceuticals (Relationship has ended)
Faculty Photos
Jason Hsu, MD
Wills Eye Physicians-Mid Atlantic Retina
Faculty
Pearse A Keane, MD
Moorfields Eye Hospital NHS Foundation Trust
United Kingdom
Faculty
Ownership-Cascader Ltd|Private Corp Stock-Big Picture Medical Ltd (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Skleo Health|Stocks or stock options, excluding diversified mutual funds-Bitfount Ltd (Relationship has ended)|Grant or research support-Roche|Royalties or Patent Beneficiary-Google|Honoraria-Bayer|Honoraria-Boehringer Ingelheim|Honoraria-Topcon Healthcare|Honoraria-Zeiss (Relationship has ended)
Ajay Kuriyan, MD
Wills Eye Hospital
Faculty
Faculty Photos
Sara E. Lally, MD
Shields and Shields
Faculty
Nothing to disclose
Faculty Photos
Beeran Meghpara, MD
Wills Eye Hospital
Faculty
Consulting Fee-Sun Pharmaceutical Industries|Speakers Bureau-Sun Pharmaceutical Industries|Consulting Fee-Glaukos Corporation|Consulting Fee-Johnson & Johnson|Speakers Bureau-Johnson & Johnson|Consulting Fee-Allergan|Consulting Fee-Sight Sciences|Consulting Fee-Dompé |Speakers Bureau-Dompé |Consulting Fee-Bio-Tissue|Consulting Fee-Tarsus|Consulting Fee-Orasis|Consulting Fee-WL Gore & Associates|Consulting Fee-Alcon|Speakers Bureau-Alcon|Consulting Fee-RxSight
Tatyana Milman , MD
Department of Pathology, Wills Eye Hospital, Philadelphia, PA
Faculty
Faculty Photos
Jonathan S. Myers, MD
Wills Eye Hospital
Faculty
Stocks or stock options, excluding diversified mutual funds-Avisi|Grant or research support-Avisi|Stocks or stock options, excluding diversified mutual funds-Microt|Stocks or stock options, excluding diversified mutual funds-Olleyes|Grant or research support-AbbVie (Relationship has ended)|Grant or research support-Glaukos Corporation|Consulting Fee-Laboratories Thea Inc|Grant or research support-Elios (Relationship has ended)|Consulting Fee-Thea Labs|Consulting Fee-Glaukos Corporation|Consulting Fee-Alcon|Grant or research support-Elios (Relationship has ended)|Consulting Fee-Genentech|Grant or research support-Haag-Streit|Consulting Fee-Injectsense|Consulting Fee-Kowa|Consulting Fee-Microt|Consulting Fee-MedPact
Faculty Photos
Ravi Patel, MD, MBA
Wills Eye Hospital
Faculty
Samir N Patel, MD
Wills Eye
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Regeneron (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)
Faculty Photos
Sagun Pendse, MD
Eye Associates of Bucks County
Faculty
Nothing to disclose
Danijel J Pericic, MD
Wills Eye Hospital
Faculty
Mark Pyfer, MD, FACS
Wills Eye Hospital
Faculty
Ahmara Ross, MD, PhD
Faculty
Faculty Photos
Joel S Schuman , MD
Wills Eye Hospital
Faculty
Consulting Fee-Zeiss|Advisor-Opticent|Private Corp Stock-Opticent|Advisor-AEYE Health|Private Corp Stock-AEYE Health|Consulting Fee-Alcon|Consulting Fee-Broadwing (Relationship has ended)|Private Corp Stock-Ocugenix|Advisor-Ocugenix|Consulting Fee-Perfuse|Consulting Fee-Perfuse (Relationship has ended)|Consulting Fee-Ocular Therpeutics (Relationship has ended)|Public Corp Stock-Ocular Therapeutix|Consulting Fee-Dompé  (Relationship has ended)|Grant or research support-Topcon|Consulting Fee-Bausch + Lomb|Consulting Fee-Johnson & Johnson|Consulting Fee-Regeneron|Public Corp Stock-Tarsus
Sarah Thornton, MD
Wills Eye Hospital
Faculty
Nothing to disclose
Faculty Photos
Brett Weinstock, MD
Friedberg Eye Associates
Faculty
Nothing to disclose
Don Zack, MD, PhD
Johns Hopkins University
Faculty
Private Corp Stock-Perceive Pharma|Consulting Fee-Perceive Pharma|Grant or research support-Perceive Pharma (Relationship has ended)
Nazlee Zebardast, MD
Massachusetts Eye and Ear
Faculty
Consulting Fee-Sanofi|Consulting Fee-Character Bio
Yuxi Zheng, MD
Faculty
Faculty Photos
Cindy Zheng , MD
Eye Physicians
Faculty
Nothing to disclose
Faculty Photos
Sunir J. Garg, MD
MidAtlantic Retina, The Retina Service of Wills Eye Hospital
Faculty, Planner
Faculty Photos
Kammi B. Gunton, MD
 
Wills Eye Hospital Pediatric Ophthalmology
Faculty, Planner
Nothing to disclose
Faculty Photos
Julia A. Haller, MD
Wills Eye
Faculty, Planner
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Topcon|Stocks or stock options, excluding diversified mutual funds-Topcon|Stocks or stock options, excluding diversified mutual funds-Bristol Myers Squibb|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Opthea (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Outlook Therapeutics (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Outlook Therapeutics (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Opthea (Relationship has ended)|Consulting Fee-Regeneron|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aura Biosciences (Relationship has ended)|Consulting Fee-Aura Biosciences (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bionic Sight LLC|Consulting Fee-Bionic Sight LLC|Consulting Fee-Seeing Medicine (Relationship has ended)
Faculty Photos
Bob Penne, MD
AFF&S
Faculty, Planner
Nothing to disclose
Faculty Photos
Christopher J. Rapuano, MD
Wills Eye Hospital
Faculty, Planner
Nothing to disclose
Faculty Photos
Carl D. Regillo, MD
Wills Eye-MAR
Faculty, Planner
Consulting Fee-AbbVie|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Consulting Fee-Novartis|Consulting Fee-Ocugen|Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Regeneron|Consulting Fee-Astellas Pharma|Consulting Fee-Ocular Therapeutix|Consulting Fee-Zeiss (Relationship has ended)|Consulting Fee-Aderum Biotechnologies, Inc.|Consulting Fee-Alcon|Consulting Fee-Bausch + Lomb|Consulting Fee-Boehringer Ingelheim
Faculty Photos
Robert C Sergott, MD
Wills Eye Hospital
Faculty, Planner
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech|Consulting Fee-Xenon Pharmaceuticals|Advisor-AstraZeneca Alexion|Advisor-Argenex|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Amgen|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Heidelberg Engineering|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Clene Nanomedicine|Membership on Advisory Committees or Review Panels, Board Membership, etc.-GenSight Biologics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Relationship has ended)
Faculty Photos
Carol L. Shields, MD
Shields and Shields MD PC
Faculty, Planner
Advisor-Aura Biosciences|Advisor-Immunocore, Inc|Advisor-Ideaya Biosciences, Inc|Advisor-iOnctura, Inc
Faculty Photos
Zeba A. Syed, MD
Wills Eye Hospital
Faculty, Planner
Speakers Bureau-Bio-Tissue|Advisor-Bio-Lattice|Consulting Fee-Bruder|Speakers Bureau-Dompé |Speakers Bureau-Tarsus|Consulting Fee-Glaukos Corporation|Consulting Fee-Recordati|Honoraria-Sun Pharmaceutical Industries|Consulting Fee-Aurion
Richard Tipperman, MD
--None--
Faculty, Planner
Advisor-Alcon
Betul N Bayraktutar, MD
Wills Eye Hospital
Peer Reviewer
Faculty Photos
Ping Huang, MD, PhD
Wills Eye
Peer Reviewer
Nothing to disclose
Faculty Photos
Aditya Kanesa-thasan, MD
Wills Eye Hospital
Peer Reviewer
Faculty Photos
charlotte marous, MD
Wills Eye Hospital
Peer Reviewer
Faculty Photos
Mark F Pyfer, MD
Northern Ophthalmic Associates
Planner
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Johnson & Johnson|Paid consultant-Johnson & Johnson|Independent Contractor (included contracted research)-Sight Sciences (Relationship has ended)|Speakers Bureau-Sight Sciences|Speakers Bureau-Rayner Surgical|Independent Contractor (included contracted research)-Tarsus (Relationship has ended)|Speakers Bureau-Tarsus|Advisor-Glaukos Corporation

Thursday, April 15, 2027
 
Research Symposium

Cutting-edge topics relevant to vision research featuring a renowned faculty of clinicians, scientists, and thought leaders who will share their latest findings and solutions.
Basic/Translational Research Free Paper Session
7:30AM - 8:25AM

Neuroprotection to Neurorestoration: New Horizons in Ophthalmic Research Panel Discussion
11:30AM - 12:00PM
Jeffrey Goldberg, MD, PhD (Faculty)
Ahmara Ross, MD, PhD (Faculty)
Ajay Kuriyan, MD (Moderator)
Don Zack, MD, PhD (Faculty)

Friday, April 16, 2027
 
Physician Program

Main conference physician program
Wills 2027
11:40AM - 11:55AM
Julia A. Haller, MD
Marriott Old City Ballroom
LUNCHEON
11:55AM - 1:10PM
Marriott Old City Ballroom
RETINA PANEL: Retina Revolution: Current Concepts and Emerging Therapies
1:10PM - 1:50PM
Carl D. Regillo, MD (Faculty)
Sunir J. Garg, MD (Faculty)
Samir N Patel, MD
David Fell, MD (Faculty)
Jason Hsu, MD (Faculty)
Yuxi Zheng, MD (Faculty)
Marriott Old City Ballroom
Gettes Lecture
1:50PM - 2:20PM
Nicole Fram, MD
Marriott Old City Ballroom
CPEC Panel
2:20PM - 2:50PM
Richard Tipperman, MD (Moderator)
Nicole Fram, MD (Faculty)
Sagun Pendse, MD (Faculty)
Colleen Halfpenny, MD (Faculty)
Brett Weinstock, MD (Faculty)
Marriott Old City Ballroom
Break & Exhibits
2:50PM - 3:20PM
Marriott Old City Ballroom
Oculoplastics Panel
3:20PM - 4:00PM
Marriott Old City Ballroom
Ellis Lecture
4:00PM - 4:30PM
Tommy Edison, BA (Faculty)
Marriott Old City Ballroom
Oncology/Pathology Panel: EyeFlix: Binge worthy breakthroughs in Ocular Oncology/Pathology
4:30PM - 5:00PM
Sara E. Lally, MD
Marriott Old City Ballroom

Moderator: Sara Lally, MD
Streaming Care: Telehealth in Ocular Oncology - Carol L. Shields, MD

Behind the Scenes: Pathology's Greatest Hits - Ralph C. Eagle Jr., MD

Coming Soon: AI, Digital Pathology, and What's Next - Tatyana Milman, MD

Blockbuster Biomarkers: Precision Medicine in Ocular Oncology - Sara Lally, MD


Dear Colleagues:

We are pleased to issue a Call for Abstracts for the Free Paper Session of the 79th Annual Wills Eye Conference. The conference, sponsored by the Wills Eye Alumni Society, will be held April 15-16, 2027. The Free Paper Session will take place on Thursday, April 15th from 1 p.m. - 6 p.m. at Wills Eye Hospital.

To be eligible to submit an abstract, you must be a current Wills Eye trainee, i.e., medical student, PGY1, resident, clinical/research fellow, or other trainee. Please specify your trainee category with your submission.

Note: This year, there will be an opportunity to present your paper at the podium or as a e-poster. Please specify your preferred format when you submit the application. Due to time constraints, we may request some who would like to present a paper to switch to a poster, and we will be in touch if this is the case. The abstract submission application will be available beginning September 1, 2026. Abstracts submitted via email will not be accepted.

The deadline to submit all abstracts is Tuesday, December 1, 2026.

The first author must be registered for the conference physician program and available to present on Thursday, April 15, 2027, otherwise the paper will be withdrawn. E-posters will be available for viewing in the MOST Lab from 12 p.m. to. 1 p.m.

We encourage you to submit abstracts that reflect the richness and breadth of research at Wills Eye and are particularly interested in papers and posters that will advance knowledge about ophthalmology and enrich our field.

If you have any questions regarding abstract submissions, please contact Susan Umfer at [email protected].

We look forward to an exciting and intellectually stimulating Free Paper Session at the 79th Annual Wills Eye Conference!

Sincerely,

Zeba A. Syed, MD
Wills Eye Conference Chair




ELIGIBILITY

To be eligible to submit an abstract and present a paper, you must be a current Wills Eye trainee, i.e., PGY1, resident, fellow, medical student, or other trainee.

INSTRUCTIONS

  • Only one paper may be submitted by each first author. Abstracts submitted should not have been previously published or presented at another meeting.
  • All abstracts must be in a structured form and include Purpose, Methods, Results, and Conclusions.
  • Deadline to submit your abstract is Tuesday, December 1, 2026.

Papers must be presented by the first author at the Free Paper Session on Thursday, April 15, 2027.

TO SUBMIT AN ABSTRACT:

Login or create an account on willseye.cloud-cme.com. The submitting author verifies upon submission that all authors have agreed to the submission of the abstract and that all information contained in the submission is true.

Abstracts will be selected for presentation based on quality and merit.

Notification of abstract acceptance will be emailed on or before Friday, January 8, 2027 to the contact author listed on the abstract. If you have not received notification by Friday, January 15, 2027, please contact Susan Umfer at [email protected] for assistance.



Submit your Abstract

View Submitted Abstracts

See us on Facebook See us on Twitter See us on YouTube See us on Linked In See us on Instagram


©2022 WILLS EYE HOSPITAL 

MISSION PEOPLE ACCREDITATION FAQs GIVING RESEARCH VISIT US PRIVACY POLICY TERMS OF USE